BNP Paribas Financial Markets
EDSA icon

BNP Paribas Financial Markets’s Edesa Biotech EDSA Stock Holding History

BNP Paribas Financial Markets’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12K Buy
+1,122
New +$10.1K ﹤0.01% 5395

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BNP Paribas Financial Markets's EDSA Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Edesa Biotech (EDSA) in Q2 2026: 1,122 shares worth $9.12K. The stake represents ﹤0.01% of the portfolio and ranks #5395 among its holdings.

33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

  • BNP Paribas Financial Markets held 1,122 shares of Edesa Biotech worth $9.12K as of Q2 2026.
  • Edesa Biotech was a new BNP Paribas Financial Markets position in Q2 2026.
  • Edesa Biotech made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5395 holding.
  • 33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.